・ Products or devices presented include future technology which may be pending regional regulatory approval and are not available for sale in all regions.
・ The contents in this website including products availability, specifications or prices are the information as of the date of announcement and are subject to change without prior notice.
・ Information is intended to be presented to the media, shareholders, investors, and other interested parties. Information about our medical products (including products currently under development) included in this website is not intended for advertising or medical advice.
・ Olympus Corporation assumes no responsibility for any damage resulting from the use of this material.
・ All company names and product names mentioned in this website are trademarks or registered trademarks of their respective companies. ® and ™ marks are not specified in this website. All trademarks and registered trademarks are the property of their respective owners.
- Jan. 20, 2023 IR(Change of Disclosure Matters) Notice Concerning Transfer of Shares of Specified Subsidiary Engaged in Scientific Solutions Business
- Jan. 18, 2023 IRNotice Regarding the Status and Completion of Stock Repurchase
- Jan. 11, 2023 IRNotice Concerning the Arbitral Award involving Consolidated Subsidiaries
- Jan. 06, 2023 IRNotice Regarding Status of Share Repurchase
- Dec. 27, 2022 IR(Change of Disclosure Matters) Notice Concerning Transfer of Shares of Specified Subsidiary Engaged in Scientific Solutions Business
- Dec. 20, 2022 IRNotice Regarding Acquisition of Odin Medical Ltd. (to make it a subsidiary) in the UK
- Dec. 20, 2022 CorporateOlympus to acquire pioneering cloud-AI endoscopy startup, Odin Vision, signifying strategic next step in the company’s broader digital strategy
- Dec. 16, 2022 IRNotice Regarding Termination of Sponsored American Depositary Receipt (ADR) Program
- Dec. 16, 2022 CorporateOlympus Named to Dow Jones Sustainability World Index for Two Consecutive Years
- Dec. 09, 2022 IRNotice of Completion of Payment for Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation System